The U.S. Centers for Disease Control and Prevention has accepted its advisory panel's recommendations on vaccines for ...

Kennedy's move appears to shortcut the CDC's outside vaccine advisers, dropping COVID vaccines from the list recommended for ...

The CDC began recommending Ixchiq last year for adults traveling to countries where chikungunya is common. The vaccine uses a live, weakened form of the virus to trigger immunity.

Chikungunya isn't prevalent in the U.S., but travelers are being told to be cautious about getting the vaccine for the ...

As of today, the COVID vaccine for healthy children and healthy pregnant women has been removed from the CDC recommended ...

Chikungunya vaccine is linked to severe complications in older adults Live virus vaccine caused hospitalizations and two ...

The approval applies to anyone aged 18 and older who has a risk of being exposed to the virus. But the FDA and the Centers ...

The FDA and CDC are recommending a pause on the use of Ixchiq (chikungunya vaccine, live) in patients 60 years and older during an ongoing safety investigation.

The U.S. Centers for Disease Control and Prevention accepted its advisory panel's recommendations on vaccines for chikungunya ...

May 21 (Reuters) - The U.S. Centers for Disease Control and Prevention has accepted its advisory panel's recommendations on vaccines for chikungunya ... of the CDC. Sign up here.